Verrucous Carcinoma — Trials

Verrucous Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

58 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: ECOG-ACRIN Cancer Research Group
Termination share: 45.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02177838	Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck Cancer	terminated	N/A	8	Rutgers, The State University of New JerseyOTHER	1	Apr 21, 2021	clinicaltrials
NCT01164566	Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy	terminated	N/A	6	Wake Forest University Health SciencesOTHER	1	Jul 2, 2018